Arena, Eisai sales and marketing update

Eisai launched Belviq XR lorcaserin extended release for chronic weight management. The wholesale acquisition cost (WAC) for a 20 mg tablet is $8.04. Belviq is approved in the U.S. as an adjunct to d...